Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Xiao Ke Wan is a traditional Chinese medicine (TCM) formula used primarily for the management of type 2 diabetes mellitus and its associated symptoms. The name "Xiao Ke" refers to "wasting and thirsting," classic symptoms of diabetes in TCM. The formulation typically contains a combination of various herbs selected for their potential effects on regulating blood sugar levels, improving insulin sensitivity, and alleviating diabetic symptoms such as excessive thirst, frequent urination, and fatigue. Some commercial formulations also include glibenclamide (a sulfonylurea antidiabetic drug) alongside herbal ingredients[1][5]. According to TCM principles, Xiao Ke Wan works by tonifying the spleen and kidney, nourishing yin, clearing heat, generating fluids to stop thirst, and rebalancing the body's energy involved in glucose metabolism[4][5]. It is especially effective for mild or moderate cases where pancreatic function remains partially intact[5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on xiao ke wan.